Try our Advanced Search for more refined results
Life Sciences - March, 2008
168 articles
- Spanish Court Upholds Pfizer's Lipitor Patent
- U.K. Yanks Cold Medicines Over Safety Concerns
- Pfizer Loses Bid To Stay Discovery In Age Bias Suit
- Doctors Slam Cholesterol Drugs Over Safety Concerns
- Cook Medical Wins Injunction Against Ex-Employees
- Judge Lets MS Drugmaker Off The Hook - For Now
- Codon, Blue Heron Settle Gene-Sythesis Patent Suit
- Medtronic Dispute With Cordis To Stay In Texas
- FTC Puts Pressure On Health, Energy Sectors: Report
- Bayer Appeals Yasmin Contraceptive Patent Invalidity
- Court Upholds Ortho-McNeil's Topamax Patent
- Courts Split Over Trademark Issues In Keyword Cases
- Amgen Threatens To Sue If Roche Launches Mircera
- FDA Says Diabetic Foot Gel Could Cause Cancer
- Shareholder Alleges Wrongdoing At NeuroMetrix
- Eisai Wins Injunction In Aricept Case
- Court Throws Out Derivative Suit Against Guidant
- FDA Seeks $2.2M For Hearing Aid Violations
- HIV Drugs May Increase Risk Of Heart Attack: FDA
- Kinks Persist In Class Action Fairness Act: Experts
- Judge Construes Claims In Carbatrol Patent Fight
- Hire Sheet: Law Firms Hired For Major IP Litigation
- FDA Demands Safety Plans For 25 Drugs, Biologics
- Judge Rejects Arguments In Bristol-Myers Case
- Invitrogen Sues GE Over Enzyme Kit Patents
- FDA Proposes More Stringent Rules For Some Stents
- Human Genome Hits Genentech With Patent Suit
- Amgen Ruling Will Increase Section 337 Investigations
- FDA Eyes Suicide Links With Merck's Singulair
- Abilify Off-Label Marketing Case Settled For $4M
- Vygon Escalates Catheter Dispute With RyMed
- Synthes Wins Bid To Stay Clamp-Patent Feud
- Court Orders Special Master In Amgen, Roche Case
- Lilly To Hand Over $15M To Settle Alaska Zyprexa Suit
- SEC Probes KV Pharmaceutical Stock Options
- Guidant MDL Lawyers Ask Judge To Reconsider Order
- Male-Enhancement Products Pose Health Risks: FDA
- Four More Countries Recall Heparin
- Pfizer's Document Bid Blocked In Celebrex Case
- Celebrity Doctor Perricone's Patents Invalidated
- Critics Say Lawyer Provision Of Vioxx Deal Is Unethical
- Pfizer Sues To Block Generic Caduet Until 2016
- Novartis Escapes Some Lotensin Claims
- AstraZeneca Gets Nod To Recruit Plaintiffs' Doctors
- AMS Alleges Biolitec Infringed Laser Probe Patent
- Forest Sues Sython To Protect Namenda Patent
- FDA Panel To Discuss New Drug Label Warnings
- 3M, News Corp. Face Suit Over Ads Printed On Floors
- 4th Circuit Rejects Wyeth Whistleblower's Appeal
- Justices Reinforce Federal Preemption In Riegel
- AWP Case Swells As Judge Certifies Another Class
- Biovail Settles With SEC For $10M
- U.S. Targets Doctors In Kickback Scheme: Report
- Neurontin Class Action To Include Generics Buyers
- Mannatech Settles Investors' Suit For $11M
- Canadian Court Upholds Lipitor Patent
- Judge Nixes Synthes Bone-Plate Patent Suit
- Some Employment Rights Still Foggy For Expats
- China Vows Closer Oversight Of Heparin Producers
- Oil-For-Food, Iraq: Grist For The Anti-Corruption Mill
- Judge Dismisses Eli Lilly ADHD Patent Dispute In Va.
- BrainLAB Hits Medtronic With $6M Bill For Legal Fees
- Judge Keeps Healthpoint Suit Alive
- Plaintiffs Are Tripped Up by Loss Causation
- FDA Finds Impurity In Suspect Heparin Batches
- Zimmer Hit With Patent Suit Over Knee Replacement
- Ranbaxy Loses Dismissal Bid In Roche Patent Spat
- Cardica's Vessel-Graft Patent Suit Survives
- Judge Questions Law In Handing Wyeth Victory
- FDA Warns Of High Mortality Rate For Medtronic Stent
- Spiriva May Increase Stroke Risk: FDA
- Indian Court Nixes Roche's Bid To Bar Generic Tarceva
- ITC Must Consider Amgen, Roche Dispute Over Mircera
- Abbott Faces Battle To Quiz Feds In AWP Suit
- FDA To Look At Efficacy Of LASIK Surgery
- Suit Says Abbott Conspired To Block Generic TriCor
- Grant & Eisenhofer Launches Whistleblower Group
- Univac Antitrust Suit V. Dentsply Gets Green Light
- Becton Dickinson Hit With Syringe Patent Suit
- Cook Wins Judgment In Heart Graft Patent Case
- CVS To Pay $36.7M To Settle Whistleblower Claims
- Amgen's Woes Worsen With Enbrel Black Box Warning
- Sanofi Aventis Sues Wockhardt Over Uroxatral Patent
- Riegel v. Medtronic: A Win For Medical Technology
- High Court Denies Cert In Blood Storage Patent Suit
- FDA Reveals Plan To Open Satellite Offices In China
- FDA To Stop All Heparin At The Border For Testing
- Legislators Introduce Follow-On Biologics Bill
- Court Won't Block Generic Zyprexa In Canada
- France's Cellectis Accuses Precision Of Infringement
- Vioxx Deal May Become Model For Future Agreements
- Novartis Faces Suit Over Children's Cough Medicine
- Wyeth Sues Watson Over Birth Control Patent
- Vertex Hit With Class Action Over Hepatitis Drug
- Judge Offers Split Decision In AWP Claim Spat
- U.S. Law Doesn't Trump State Claim In Paxil Suit
- Nutraceutical Execs Ordered To Pay $1M
- FDA Advises Virtual Ban On Amgen, J&J Anemia Drugs
- DOJ Faces Scrutiny Over Corporate Monitor Guidelines
- Germany Asks Cos. To Look For Tainted Heparin
- Compulsory License Battle Moves To Indian Court
- HIV Drug Potentially Tied To Liver Damage
- Preemption On The Mind: Recent High Court Rulings
- Planned Parenthood Accused Of Vast Overbilling
- Rx.com Suffers Blow In Antitrust Case
- FDA Regulations Expert Joins Baker Hostetler
- Teva's Counterclaims Against ADHD Patent To Stand
- Three Japanese Cos. Recall Heparin Products
- FDA Gives OK To Miss Some Drug Approval Deadlines
- What Supplemental Briefing Bodes For Bilski
- FDA Reappoints Former Chief Of Drug Safety Center
- Ailing Vitamin Co. Seeks Refuge In Bankruptcy
- Sanofi Sues Sandoz To Protect Ambien Patent
- Edwards LifeSciences Hit With $40M Verdict
- FDA Issues Word Of Caution Over Tussionex
- Gene Therapy Cos. Settle Patent Suit
- USV Patents Method To Make Aricept Ingredient
- Lilly's Greed Steered Course Over Zyprexa: Official
- Black Box Warning Strengthened On Anemia Drugs
- Thailand Does About-Face On Cancer Drug Patents
- Drug Giants Broker $125M Deal In AWP Suit
- Government Seeks To Quash Abbott Subpoenas
- Innogenetics Court Likens Royalty Award To License
- Judge OKs Webcast Of Zyprexa Hearing
- Cardinal Health Plaintiffs Sent Back To Drawing Board
- One Patent Tossed, Two Upheld In Celebrex Appeal
- Conn. Jumps Into Zyprexa Fray With Lawsuit
- Wyeth, Upjohn Hit With $27M In Punitive Damages
- India's New Patent Regime: Impact On Global Pharmas
- FDA Asks GSK, Others For Data On Asthma Drugs
- Attacks On Patent Trolls Draw Concerns
- GSK Probe Prompts U.K. To Boost Drug Oversight
- FDA Warns Internet Sellers Of Unapproved STD Drugs
- Timing Of Recalls Poses Challenges For Medical Cos.
- Impax Says Pfizer's Detrol Patent Suit Is Baseless
- U.S. Officials Concede Vaccines Led To Disorder
- Business Conduct Guidelines For Health Care
- Teva Sues FDA Over Delisted Risperdal Patent
- Dr. Reddy's Loses Bid To Invalidate Teva Patents
- Roche Warns Of Psychotic Reactions To Tamiflu
- Supreme Court Ruling Could Impact Aredia Case
- Medtronic Faces Stent Patent Suit From J&J, Wyeth
- Powell Gilbert Adds IP Partner
- Biotech Co. Counsel Moves Back To Proskauer
- Drug Safety Concerns Prompt GAO Probe Of FDA
- Barr Sues Watson Over Seasonique Patent
- Pfizer Quits Bickering Over Mirapex Bellwether Trials
- Court Finds Listerine Class Bid Hard To Swallow
- Tyco, Bondholders Spin-Off Dispute Continues
- FDA Unlikely To Curb Off-Label Marketing: Sources
- Bayer Patent Invalidated Due To Obviousness
- Schering-Plough Loses Suit Over Laxative Marketing
- Judge Tosses Suit Over Barr's Morning-After Pill
- Seroquel Plaintiffs Win Bid To Quiz Doctors
- Makers Of Impotence Drugs Fined $1M
- High Court Recusals Questioned After Split Rulings
- Bellwether Case Picked For Lens Solution MDL
- Allergan Faces DOJ Subpoena Over Botox
- More FTC Officials Head Back To Private Sector
- Eli Lilly Gears Up For Zyprexa Showdown
- Judge Tosses Suit Against Anthrax Vaccine Policy
- Plaintiffs Signing On To $5B Vioxx Deal: Merck
- Wyeth Wins Dimissal Of Weight-Loss Drug Suit
- Punitive Damages Possible In Wyeth Hormone Trial
- Supreme Court Deadlock Lets Rezulin Case Advance
- Goodwin Procter Attracts Biotech Patent Standout
- A Paradigm Shift In Obviousness For Pharma, Biotech
- Teva Faces Infringement Suits Over TriCor Patent